Vietnam's Pharmaceutical Strategy: Aiming for ASEAN Leadership by 2030
The Ministry of Health recently introduced the National Pharmaceutical Development Strategy, with a target for 2030 and a vision for 2045. This strategy focuses on prioritizing domestic pharmaceutical companies and manufacturers with production facilities in Vietnam, aiming to increase self-sufficiency and reduce reliance on imports.
Key elements of Vietnam's pharmaceutical strategy include:
- Development of the domestic pharmaceutical industry: Emphasizing the production of originator drugs, new drug formulations, and biological drugs, with the goal of reaching level 4 according to WHO standards.
- Enhancing production capacity: Elevating the pharmaceutical sector to match advanced countries, establishing Vietnam as a hub for the production and technology transfer of originator drugs within ASEAN.
- Expanding the pharmaceutical sector's role: Moving beyond product supply to include involvement in healthcare services and clinical pharmacy.
- Building a digital health ecosystem: Developing a platform for monitoring and optimizing drug use, ensuring traceability and quality control.
While this strategy supports the growth of domestic companies, could it create long-term challenges for imported products? How can we balance fostering domestic growth with embracing global innovation in the pharmaceutical sector?
Read the full article at: https://moh.gov.vn/hoat-dong-cua-lanh-dao-bo/-/asset_publisher/TW6LTp1ZtwaN/content/hoi-nghi-trien-khai-chien-luoc-quoc-gia-phat-trien-nganh-duoc-viet-nam?
